19-11059810-GAGA-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_003072.5(SMARCA4):c.4696_4698delAAG(p.Lys1566del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,032 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
SMARCA4
NM_003072.5 conservative_inframe_deletion
NM_003072.5 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.24
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4792_4794delAAG | p.Lys1598del | conservative_inframe_deletion | 34/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4696_4698delAAG | p.Lys1566del | conservative_inframe_deletion | 33/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4792_4794delAAG | p.Lys1598del | conservative_inframe_deletion | 34/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4696_4698delAAG | p.Lys1566del | conservative_inframe_deletion | 33/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4702_4704delAAG | p.Lys1568del | conservative_inframe_deletion | 33/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4606_4608delAAG | p.Lys1536del | conservative_inframe_deletion | 33/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4606_4608delAAG | p.Lys1536del | conservative_inframe_deletion | 32/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4606_4608delAAG | p.Lys1536del | conservative_inframe_deletion | 32/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4603_4605delAAG | p.Lys1535del | conservative_inframe_deletion | 33/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4117_4119delAAG | p.Lys1373del | conservative_inframe_deletion | 30/32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3346_3348delAAG | p.Lys1116del | conservative_inframe_deletion | 26/28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3328_3330delAAG | p.Lys1110del | conservative_inframe_deletion | 25/27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3190_3192delAAG | p.Lys1064del | conservative_inframe_deletion | 25/27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2956_2958delAAG | p.Lys986del | conservative_inframe_deletion | 23/25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.760_762delAAG | p.Lys254del | conservative_inframe_deletion | 6/8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000410 AC: 1AN: 243852Hom.: 0 AF XY: 0.00000756 AC XY: 1AN XY: 132206
GnomAD3 exomes
AF:
AC:
1
AN:
243852
Hom.:
AF XY:
AC XY:
1
AN XY:
132206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459816Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 726068
GnomAD4 exome
AF:
AC:
2
AN:
1459816
Hom.:
AF XY:
AC XY:
2
AN XY:
726068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74366
GnomAD4 genome
AF:
AC:
1
AN:
152216
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Oct 29, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.4792_4794delAAG variant (also known as p.K1598del) is located in coding exon 33 of the SMARCA4 gene. This variant results from an in-frame AAG deletion at nucleotide positions 4792 to 4794. This results in the in-frame deletion of a lysine at codon 1598. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). This variant has been detected in multiple individuals with no reported features of Coffin-Siris syndrome (Ambry internal data). Based on the supporting evidence, the association of this alteration with rhabdoid tumor predisposition syndrome is unknown; however, the association of this alteration with Coffin-Siris syndrome is unlikely. - |
Intellectual disability, autosomal dominant 16 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | This variant, c.4792_4794del, results in the deletion of 1 amino acid(s) of the SMARCA4 protein (p.Lys1598del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 537796). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 01, 2023 | In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at